Apr 27
Proxy statement
DEF 14A
Meeting Jun 8, 2023
Proxy statement
MRMD · Marimed Inc. · Documents
$0.08
+0.00 (+3.22%)
At close · Nov 12
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$30.99M
Shares
403.04M
Volume · Nov 12
155.66K
Avg daily vol (3M)
772.65K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2023
Apr 17
Current report
8-K
Director or officer change, or executive pay, Other events
Mar 6
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2022
Mar 6
Current report
8-K
Events of Feb 28
Charter or bylaw amendment, or fiscal year change
Mar 3
Annual report
10-K
FY2022, ended Dec 31
Annual report for FY2022
Revenue $134.01M
▲ 10.3%
Net income $13.47M
▲ 86.4%
Diluted EPS $0.04
▲ 100.0%
Mar 1
Current report
8-K
Financial results
Jan 24
2022
Dec 14
Current report
8-K
Other events
Dec 12
Current report
8-K
Other events
Nov 8
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $33.91M
▲ 2.1%
Net income $2.71M
▲ 34.0%
Diluted EPS $0.01
▲ unchanged
Nov 7
Current report
8-K
Financial results
Oct 31
Current report
8-K
Events of Oct 27
Shareholder vote results
Sep 22
Proxy statement
DEF 14A
Proxy statement
Sep 7
Current report
8-K
Director or officer change, or executive pay, Other events
Aug 9
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $32.99M
▲ 1.3%
Net income $1.82M
▼ 75.7%
Diluted EPS $0.00
Aug 8
Current report
8-K
Financial results
May 18
Current report
8-K
Events of May 12
Director or officer change, or executive pay
May 16
Current report
8-K
Events of May 10
Financial results, Regulation FD disclosure
May 10
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $31.28M
▲ 26.9%
Net income $4.19M
▼ 0.8%
Diluted EPS $0.01
▲ unchanged
Apr 14
Current report
8-K
Other events
Mar 21
Current report
8-K
Events of Mar 16
Financial results, Regulation FD disclosure
Mar 16
Annual report
10-K
FY2021, ended Dec 31
Annual report for FY2021
Revenue $121.46M
▲ 138.7%
Net income $7.22M
▲ 237.0%
Diluted EPS $0.02
▲ 100.0%
Jan 5
Current report
8-K
Events of Dec 31
Entered into a material agreement
2021
Nov 18
Current report
8-K
Events of Nov 15
Financial results, Regulation FD disclosure
Nov 15
Quarterly report
10-Q
FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $33.21M
▲ 146.7%
Net income $2.02M
▲ 21.8%
Diluted EPS $0.01
Sep 28
Current report
8-K
Events of Sep 23
Shareholder vote results
Aug 19
Current report
8-K
Events of Aug 16
Financial results, Regulation FD disclosure
Aug 17
Proxy statement
DEF 14A
Proxy statement
Aug 16
Quarterly report
10-Q
FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $32.57M
▲ 238.9%
Net income $7.49M
Diluted EPS $0.02
Jul 23
Proxy statement
PRE 14A
Proxy statement
Jul 9
Current report
8-K
Director or officer change, or executive pay
May 20
Current report
8-K
Events of May 17
Financial results, Regulation FD disclosure
May 17
Quarterly report
10-Q
FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $24.64M
▲ 230.1%
Net income $4.22M
Diluted EPS $0.01
Apr 19
Registration statement
S-3
Registration statement
Apr 1
Current report
8-K
Entered into a material agreement
Mar 26
Current report
8-K
Events of Mar 23
Financial results, Regulation FD disclosure
Mar 23
Annual report
10-K
FY2020, ended Dec 31
Annual report for FY2020
Revenue $50.9M
▲ 11.6%
Net income $2.14M
Diluted EPS $0.01
Mar 2
Current report
8-K
Events of Mar 1
Entered into a material agreement, Charter or bylaw amendment, or fiscal year change, Other events
2020
Nov 16
Current report
8-K
Events of Nov 9
Financial results, Regulation FD disclosure
Nov 9
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $13.46M
▲ 19.9%
Net income $1.66M
Diluted EPS $0.01
Oct 26
Current report
8-K
Events of Oct 20
Entered into a material agreement
Aug 11
Current report
8-K
Events of Aug 10
Other events
Aug 10
Quarterly report
10-Q
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $9.61M
▼ 62.6%
Net loss $1.21M
Diluted EPS $0.00
Jul 23
Current report
8-K
Other events
Jun 30
Current report
8-K
Events of Jun 24
Entered into a material agreement
May 28
Quarterly report
10-Q
FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $7.47M
▲ 112.4%
Net loss $2.42M
May 12
Current report
8-K
Other events
May 11
Current report
8-K
Other events
Apr 29
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2019
Apr 1
Annual report
10-K
FY2019, ended Dec 31
Annual report for FY2019
Revenue $45.6M
▲ 284.8%
Net loss $81.18M
Showing 51–100 of 104 documents